Protein Arginine Deiminase (PAD) Inhibitors

Protein Arginine Deiminase (PAD) inhibitors are cutting-edge compounds that have garnered significant attention in the field of biochemistry These inhibitors target the enzymatic activity of PAD enzymes which are responsible for the citrullination of proteins By blocking this activity PAD inhibitors have the potential to modulate various biological processes that are regulated by protein citrullination This novel class of inhibitors holds promise for the development of therapies for autoimmune diseases neurodegenerative disorders and certain cancers As a leading provider of PAD inhibitors our company offers a diverse range of high-quality compounds that are meticulously designed and rigorously tested for their efficacy and safety

Catalog Number	Chemical Name	CAS #	Price
EI-0355	BCH001	384859-58-9	Online Inquiry
EI-1086	GSK-106 hydrochloride	1652591-82-6	Online Inquiry
EI-1089	GSK-121 trifluoroacetate	1652591-80-4	Online Inquiry
EI-1092	GSK-199 hydrochloride	1549811-53-1	Online Inquiry
EI-1116	GSK-484 hydrochloride	1652591-81-5	Online Inquiry
EI-3371	F-Amidine (trifluoroacetate salt)	877617-46-4	Online Inquiry

Application

Protein Arginine Deiminase (PAD) inhibitors have a wide range of applications in both research and medicine In the field of research these inhibitors are used to study the role of PAD enzymes in various biological processes and diseases By blocking the activity of PAD enzymes scientists can gain valuable insights into the function of these enzymes and their impact on cellular processes

In the medical field PAD inhibitors have shown promise as potential therapeutic agents for diseases such as rheumatoid arthritis and multiple sclerosis By inhibiting the activity of PAD enzymes these inhibitors can help reduce the production of citrullinated proteins which are known to contribute to autoimmune reactions and inflammation This offers potential for the development of novel treatments for these debilitating conditions

Furthermore PAD inhibitors have also been investigated for their potential in cancer therapy It has been found that PAD enzymes play a role in cancer progression and metastasis By inhibiting their activity PAD inhibitors may help inhibit tumor growth and metastasis offering a new avenue for cancer treatment

Overall the applications of Protein Arginine Deiminase (PAD) inhibitors are diverse and hold great potential in both research and medicine Their ability to modulate PAD enzyme activity opens up new possibilities for understanding diseases and developing targeted therapies

Please note that all services are for research use only. Not intended for any clinical use.

Protein Arginine Deiminase (PAD) Inhibitors